ADAR1 Capital Management LLC decreased its stake in Adagio Medical Holdings, Inc. (NASDAQ:ADGM – Free Report) by 48.4% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 76,757 shares of the company’s stock after selling 72,104 shares during the period. ADAR1 Capital Management LLC owned 0.50% of Adagio Medical worth $81,000 as of its most recent filing with the Securities and Exchange Commission.
Separately, Shaolin Capital Management LLC bought a new stake in Adagio Medical in the third quarter valued at approximately $361,000. Institutional investors own 48.08% of the company’s stock.
Adagio Medical Stock Performance
NASDAQ:ADGM opened at $0.77 on Tuesday. The company has a debt-to-equity ratio of 0.18, a current ratio of 4.42 and a quick ratio of 3.90. Adagio Medical Holdings, Inc. has a fifty-two week low of $0.63 and a fifty-two week high of $9.34. The company has a 50 day simple moving average of $1.07 and a two-hundred day simple moving average of $1.78.
Adagio Medical Profile
Adagio Medical Holdings, Inc, a developmental stage medical device company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, atrial flutter, and ventricular tachycardia.
Recommended Stories
- Five stocks we like better than Adagio Medical
- Overbought Stocks Explained: Should You Trade Them?
- Options Activity Points to More Volatility for Palantir Stock
- Expert Stock Trading Psychology Tips
- NVIDIA Stock: Oversold, Undervalued — How Low Can It Go?
- CD Calculator: Certificate of Deposit Calculator
- MicroStrategy Sees Insider Buy-Sell Action in Q1
Want to see what other hedge funds are holding ADGM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Adagio Medical Holdings, Inc. (NASDAQ:ADGM – Free Report).
Receive News & Ratings for Adagio Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adagio Medical and related companies with MarketBeat.com's FREE daily email newsletter.